Get the Stockscreener App
2.63
0.38%
-0.01
Treace Medical Concepts Inc stock is traded at $2.63, with a volume of 30,601.
It is down -0.38% in the last 24 hours and down -4.02% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$2.64
Open:
$2.63
24h Volume:
30,601
Relative Volume:
0.04
Market Cap:
$167.58M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-2.5729
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
+6.04%
1M Performance:
-4.02%
6M Performance:
-57.44%
1Y Performance:
-66.24%
1-Day Range:
$2.5859
$2.6556
1-Week Range:
$2.42
$2.705
52-Week Range:
$2.36
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
2.63 | 168.22M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
128.65 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.42 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.74 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.80 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.72 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 0.8%Time to Sell? - MarketBeat
Why hedge funds are buying Treace Medical Concepts Inc. stockWeekly Market Snapshot & Low Entry Cost Capital - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2025 Winners & Losers & Free Reliable Trade Execution Plans - Улправда
What valuation multiples suggest for Treace Medical Concepts Inc. stock2025 Retail Activity & Capital Efficiency Focused Ideas - Улправда
Treace Medical raises USD 175M in debt financing - Medical Buyer
Will Treace Medical Concepts Inc. stock recover faster than marketOil Prices & Safe Entry Zone Identification - DonanımHaber
Is Treace Medical Concepts Inc. stock a contrarian buy2025 Winners & Losers & Free High Return Stock Watch Alerts - Улправда
Is Treace Medical Concepts Inc. stock resilient to inflationWeekly Loss Report & Safe Entry Momentum Stock Tips - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Treace Medical Concepts (TMCI) Analyst Rating Update: Truist Sec - GuruFocus
How Treace Medical Concepts Inc. stock compares to industry benchmarks2025 Bull vs Bear & Stepwise Entry and Exit Trade Signals - Улправда
Treace Medical Concepts, Inc. Secures Up to $175 Million in Debt Financing - marketscreener.com
Truist Securities Trims Price Target on Treace Medical Concepts to $3 From $4, Maintains Hold Rating - marketscreener.com
Treace Medical secures up to $175 million in debt financing - marketscreener.com
Treace Medical Secures Up To $175 Million In Debt Financing - TradingView — Track All Markets
Treace Medical Completes New Secured Loan Financing Deal - TipRanks
Treace Medical Secures Up to $175 Million in Debt Financing - The Manila Times
Treace Medical Concepts Announces $175 Million Secured Loan Agreement to Enhance Financial Flexibility and Market Position - Quiver Quantitative
[8-K] TREACE MEDICAL CONCEPTS, INC. Reports Material Event | TMCI SEC FilingForm 8-K - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionTMCI - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2025-12-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation | NDAQ:TMCI | Press Release - Stockhouse
Stock Recap: Will Treace Medical Concepts Inc stock recover faster than marketQuarterly Earnings Report & Reliable Intraday Trade Plans - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
What Analysts Think Is Shifting The Story For Treace Medical Concepts Now - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Treace Medical Concepts Inc. stock recover faster than peersJuly 2025 Pullbacks & Long-Term Growth Plans - Newser
Patterns Watch: Why hedge funds are buying Treace Medical Concepts Inc stockWeekly Earnings Recap & Real-Time Price Movement Reports - BỘ NỘI VỤ
Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI) - GlobeNewswire
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Sh - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Urged to Join - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
CenterBook Partners LP Purchases Shares of 562,710 Treace Medical Concepts, Inc. $TMCI - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
How Recent Developments Are Reshaping the Treace Medical Concepts Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Should you wait for a breakout in Treace Medical Concepts Inc.Market Activity Summary & Trade Opportunity Analysis - newser.com
How currency fluctuations impact Treace Medical Concepts Inc. stockJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Treace Medical Concepts (TMCI) Price Target Decreased by 35.65% to 5.58 - MSN
Is Treace Medical Concepts Inc. stock poised for growthInflation Watch & Technical Pattern Based Buy Signals - newser.com
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):